SQL Technologies (NASDAQ:SKYX) reported quarterly losses of $(0.06) per share. The company reported $7.39 thousand in sales this quarter.
Eterna Therapeutics On Nov. 23 Entered Securities Purchase Agreement Providing For Private Placement To Purchasers Of 2,184,950 Units
ERNA On November 23, 2022, Eterna Therapeutics Inc., a Delaware corporation (the "Company"), entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain investors (the